We combine our next-generation sequencing process and analysis pipelines with our medical expertise. Our dedicated team of scientists and bioinformaticians works closely with you to develop the best strategy for the realization of your project. Depending on its scope we select the most suitable library preparation and sequencer from our Illumina platforms.
CeGaT, founded in 2009 and based in Tübingen, Germany, is accredited according to CAP, CLIA and DIN EN ISO 15189:2014. Recently CeGaT cooperated with B. Braun to create the joint venture CeCaVa, which stands for “Center for Cancer Vaccines”. The new company is devoted to developing individualized vaccines that are to be used to treat diseases, particularly tumorous diseases.
Follow CeGaT at social networks and Stand No.25